Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Keros Therapeutics Authorizes Additional $5 Mln Share Repurchase Program

(RTTNews) - Keros Therapeutics, Inc. (KROS), a clinical-stage biopharmaceutical company, on Monday announced that its board of directors has approved an additional $5 million share repurchase program.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Tuesday 17 November →